What is the prevalence and burden of pseudoexfoliation syndrome in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pseudoexfoliation syndrome affects approximately 6-7.5% of the Indian population aged over 40 years, with a significant increase in prevalence with age, reaching 15-20% in those over 70 years, resulting in a substantial burden on the healthcare system and quality of life 1. The prevalence of pseudoexfoliation syndrome in India varies geographically, with higher rates observed in southern states such as Tamil Nadu, Karnataka, and Andhra Pradesh compared to northern regions.

  • Key factors contributing to the burden of pseudoexfoliation syndrome in India include:
    • Advanced age
    • Female gender
    • Outdoor occupation with UV exposure
    • Possible genetic factors specific to South Asian populations The condition is characterized by the deposition of whitish fibrillar material on ocular structures, leading to serious complications including:
  • Glaucoma (pseudoexfoliation glaucoma occurs in 25-30% of PXF patients)
  • Cataracts
  • Increased surgical complications Early detection through comprehensive eye examinations is crucial, as PXF-related glaucoma tends to progress more rapidly and respond less effectively to treatment than primary open-angle glaucoma, often requiring more aggressive management approaches 1. The economic burden of glaucoma, including pseudoexfoliation glaucoma, is substantial, with estimated average annual direct medical costs ranging from $623 for early glaucoma to $2511 for end-stage glaucoma, highlighting the need for effective and cost-efficient management strategies 1.

From the Research

Prevalence of Pseudoexfoliation Syndrome in India

  • The prevalence of pseudoexfoliation syndrome in India has been reported to be around 3.73% in a south Indian population 2.
  • Another study found a prevalence of 3.8% in a rural population of south India 3.
  • A more recent study using electronic medical record-driven big data analytics found a prevalence of 0.75% in patients presenting to a multi-tier ophthalmology hospital network in India 4.

Burden of Pseudoexfoliation Syndrome in India

  • Pseudoexfoliation syndrome is associated with an increased risk of glaucoma, with 8.3% of patients with pseudoexfoliation syndrome also having glaucoma 2.
  • The condition is also associated with ocular hypertension, occludable angles, and cataract 2, 3.
  • Patients with pseudoexfoliation syndrome have a higher risk of vision loss and a higher maximum and mean intraocular pressure at diagnosis compared to primary open-angle glaucoma 5.
  • The majority of patients with pseudoexfoliation syndrome have mild or no visual impairment, but a quarter of affected eyes are associated with glaucoma 4.

Demographic Distribution of Pseudoexfoliation Syndrome in India

  • Pseudoexfoliation syndrome more commonly affects males, with 67.08% of patients being male 4.
  • The majority of patients present during the seventh decade of life, with 40.89% of patients being in this age group 4.
  • The condition is predominantly unilateral, with 60.96% of patients having unilateral affliction 4.
  • Patients from a lower socio-economic status and those presenting from urban geography are more likely to have pseudoexfoliation syndrome 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.